A portable fingerstick device for measuring blood triglycerides shows strong agreement with traditional lab tests in pregnant women with obesity or gestational diabetes, according to a 2026 study of 35 women. The portable device readings matched lab results with 86% agreement when fasting and 84% agreement after eating, suggesting it could become a practical home-monitoring tool for tracking a risk factor linked to excessive baby growth.
Researchers tested a new portable device that measures fat levels in blood using just a fingerstick, similar to how diabetics check blood sugar. The study involved 35 pregnant women with weight or diabetes concerns. According to Gram Research analysis, the portable device matched laboratory blood tests very closely, suggesting it could help doctors better understand and prevent problems with baby growth during pregnancy. This easier testing method might help pregnant women get more frequent checks without painful needle sticks.
Key Statistics
A 2026 study of 35 pregnant women found that a portable fingerstick triglyceride meter showed 86% agreement with traditional lab blood tests for fasting measurements and 84% agreement for measurements taken after eating.
In the 2026 research of 35 pregnant women with obesity or gestational diabetes, the portable triglyceride device readings were only 4.6% lower than lab results when fasting and 12% higher after eating, indicating clinically acceptable agreement.
A 2026 validation study involving 35 pregnant women collected 68 paired fasting triglyceride measurements and 52 paired post-meal measurements, demonstrating the feasibility of frequent home-based triglyceride monitoring in high-risk pregnancies.
The Quick Take
- What they studied: Whether a simple fingerstick device that measures triglycerides (a type of fat in blood) works as well as traditional blood tests taken from a vein in pregnant women.
- Who participated: 35 pregnant women, average age around 25-35 weeks into pregnancy, who were overweight or had gestational diabetes. About 59% had obesity alone, and 41% had gestational diabetes.
- Key finding: The portable fingerstick device showed 86% agreement with traditional lab tests for fasting measurements and 84% agreement after eating. The portable device readings were only about 4-12% different from lab results.
- What it means for you: Pregnant women with weight or diabetes concerns may soon be able to check their blood fat levels at home using a simple fingerstick test, making it easier to monitor a risk factor for baby overgrowth. However, this is still being studied and isn’t yet standard care.
The Research Details
Researchers recruited 35 pregnant women with obesity or gestational diabetes and compared two ways of measuring triglycerides (blood fats). First, they took traditional blood samples from a vein in the arm at the same time as fingerstick samples using a portable device. They collected 68 paired fasting measurements. Then, 23 of these women ate a controlled breakfast and had their blood fat levels measured 1 and 2 hours later using both methods, collecting 52 additional paired measurements.
The study used statistical methods called intraclass correlation and Bland-Altman plots to see how closely the two methods agreed. These are standard ways to check if two different measurement methods give similar results. The researchers also used paired t-tests to look for any systematic differences between the methods.
Currently, measuring blood triglycerides requires a needle stick and a trip to a lab, which discourages frequent testing. If a portable device works just as well, pregnant women could test themselves at home multiple times, helping doctors understand how blood fats affect baby growth. This is important because recent research suggests blood fat levels may be a better predictor of baby overgrowth than glucose alone in obese pregnancies.
This is a small study with 35 participants, which limits how much we can generalize the findings. The study was well-designed with careful timing of measurements (within 5 minutes of each other) and used appropriate statistical methods. The researchers used an FDA-approved device, which adds credibility. However, the study doesn’t yet show whether using this device actually improves pregnancy outcomes—it only shows the device gives accurate readings.
What the Results Show
The portable fingerstick device and traditional lab tests showed strong agreement for measuring fasting triglycerides. The agreement score was 0.86 out of 1.0 (where 1.0 is perfect agreement). On average, the portable device readings were only 4.6% lower than lab results, with a range of variation of about ±18%.
For measurements taken after eating (postprandial triglycerides), the agreement was also good at 0.84 out of 1.0. However, the portable device readings were about 12% higher than lab results after eating, with more variation (±12%). This means the device is slightly less accurate after meals but still shows acceptable agreement.
All differences between the two methods were statistically significant, meaning the portable device consistently read slightly differently than lab tests. However, the differences were small enough that the device could be clinically useful for tracking changes over time.
The study found that the portable device worked reasonably well in both fasting and fed states, suggesting it could be used flexibly without requiring women to fast. The consistency of the measurements (how close repeated tests were to each other) was good for both methods. The researchers noted that the portable device could help identify which pregnant women have elevated blood fats that might contribute to excessive baby growth.
This is one of the first studies testing portable triglyceride devices in pregnant women. Previous research has shown that blood triglycerides may be better predictors of fetal overgrowth than glucose alone in obese pregnancies, but measuring them has been impractical. This study builds on that research by showing a practical way to measure triglycerides repeatedly. Similar portable devices have been validated in non-pregnant populations, but pregnancy changes how the body handles fats, so this specific validation was needed.
The study included only 35 women, which is a small sample size. Results may not apply to all pregnant women, especially those of different ethnicities or with different types of obesity. The study only tested one brand of portable device, so results may not apply to other devices. The study didn’t follow babies after birth to see if using this device actually prevents complications—it only showed the device gives accurate readings. The study was done at a single medical center, which may limit how widely the findings apply.
The Bottom Line
This research supports further development and testing of portable triglyceride devices for pregnant women with obesity or gestational diabetes. The device shows promise for home monitoring, but it’s not yet recommended as standard care. Pregnant women should continue following their doctor’s advice about blood testing. If your doctor recommends triglyceride monitoring, ask whether portable testing might be available in the future. (Confidence: Moderate—based on good technical agreement but limited sample size and no outcome data)
This research is most relevant to pregnant women with obesity or gestational diabetes, their doctors, and researchers developing better monitoring tools. Women with normal pregnancies don’t need triglyceride monitoring. Healthcare providers managing high-risk pregnancies should be aware this technology is being validated. Researchers studying fetal growth and metabolic disease in pregnancy should follow this work.
This is early-stage research. It will likely take 2-5 years before portable triglyceride devices become available for home use in pregnant women, if they’re approved. Even then, they would likely be recommended only for women with specific risk factors like obesity or gestational diabetes.
Frequently Asked Questions
Can pregnant women use a fingerstick triglyceride meter at home like a glucose meter?
Research shows a portable fingerstick triglyceride device matches lab tests with 86% accuracy when fasting and 84% after eating in pregnant women. However, it’s not yet available for home use—this 2026 study was the first validation in pregnancy, and further testing is needed before it becomes standard care.
Why do doctors care about triglycerides during pregnancy?
Recent research suggests blood triglycerides may be a stronger predictor of excessive baby growth than glucose alone in obese pregnancies. Monitoring triglycerides could help identify pregnant women at risk and guide treatment to prevent complications for both mother and baby.
How accurate is the portable triglyceride device compared to blood tests?
The 2026 study found the portable device was only 4-12% different from lab results, with strong statistical agreement (0.84-0.86 out of 1.0). These differences are small enough for clinical use, though the device is slightly less accurate after meals than when fasting.
Who would benefit most from home triglyceride monitoring during pregnancy?
Pregnant women with obesity or gestational diabetes would benefit most, as they have higher triglyceride levels and greater risk of fetal overgrowth. Women with normal pregnancies don’t typically need triglyceride monitoring. Your doctor can determine if you’re a candidate.
When will portable triglyceride meters be available for pregnant women?
This 2026 study is early-stage validation. It will likely take 2-5 years of additional research before portable triglyceride devices are approved and available for home use in pregnancy, and only for high-risk women.
Want to Apply This Research?
- If using a portable triglyceride meter becomes available, track fasting and postprandial (after-meal) triglyceride readings weekly, recording the time of day, whether fasting, and what was eaten before the test. This creates a pattern showing how diet affects blood fat levels.
- Users could log triglyceride readings in the app alongside meal photos and timing, creating a visual connection between eating patterns and blood fat levels. This might motivate dietary changes that help manage triglycerides during pregnancy.
- Set up weekly reminders for fasting triglyceride checks (same day and time each week) and post-meal checks 1-2 hours after a standard breakfast. Track trends over weeks to see if dietary changes are working, and share results with your healthcare provider at appointments.
This research describes a validation study of a portable device and does not yet constitute a clinical recommendation. Pregnant women should not use any home testing device without explicit guidance from their healthcare provider. This study does not prove that monitoring triglycerides improves pregnancy outcomes. All pregnancy-related health decisions should be made in consultation with your obstetrician or maternal-fetal medicine specialist. If you have obesity or gestational diabetes, discuss appropriate monitoring strategies with your doctor.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.